List of insiders holdings for ANI PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
MERIDIAN VENTURE PARTNERS II LP
Meridian Venture Partners II GP L.P.
Meridian Venture Partners II Co.
Brown Robert E. JR
10% Owner
2022-12-12 16:00:422,068,280
0
2,068,280Form 13D
Shanmugam Muthusamy
HEAD OF R & D COO-NOVITIUM OPS
2022-03-21 21:58:1218,460
1,337,620
1,356,080Form 4
SIMES STEPHEN M
Vice Chairman President & CEO
2012-01-27 16:29:26800,000
202,267
1,002,267Form 4
EDELMAN JOSEPH
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
PERCEPTIVE ADVISORS LLC
Cho Michael
10% Owner
2004-12-13 16:48:36709,819
0
709,819Form 13G
EDELMAN JOSEPH
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
PERCEPTIVE ADVISORS LLC
10% Owner
2004-12-13 16:48:36709,819
0
709,819Form 13G
Gassert Chad
SVP - CORP. DEV. & STRATEGY
2022-03-22 17:37:550
393,226
393,226Form 4
MARSHBANKS TRACY
Director
2018-05-16 16:22:180
349,934
349,934Form 4
DONENBERG PHILIP B
Sr VP of Finance CFO Secy
2012-01-27 16:33:48329,322
0
329,322Form 4
RAYNOR DANIEL
Director
2018-03-19 16:54:290
289,003
289,003Form 4
Lalwani Nikhil
PRESIDENT & CEO
2022-09-12 20:15:40281,957
0
281,957Form 4
PRZYBYL ARTHUR
President and CEO
2020-04-08 17:54:20190,309
0
190,309Form 4
Snabes Michael C
Sr. VP of Medical Affairs
2012-01-27 16:37:45165,000
0
165,000Form 4
LEHMAN LEAH M
VP Product Development
2005-08-25 15:16:38150,000
0
150,000Form 4/A
CAREY STEPHEN P.
SENIOR VICE PRESIDENT AND CFO
2022-04-29 18:34:09146,633
0
146,633Form 4
Marken James G.
SVP OPS & PROD DEV
2022-08-16 21:01:19117,642
0
117,642Form 4
SHERWIN STEPHEN A
Director
2012-03-30 17:27:49111,760
0
111,760Form 4
Schrepfer Robert W
SVP - NEW BUS DEV & SPEC SALES
2021-03-29 20:11:2387,477
0
87,477Form 4
SULLIVAN LOUIS W
Director
2012-03-30 17:38:2282,898
0
82,898Form 4
Jamnick Robert J.
VP Quality & Product Develop.
2014-05-27 16:38:1177,701
0
77,701Form 4
HO ANGELA
Director
2004-03-22 15:48:2972,137
0
72,137Form 4
Walsh Patrick D
Director
2022-04-29 18:24:2263,437
0
63,437Form 4
Arnold Charlotte C.
Vice President and CFO
2016-04-11 19:10:1662,298
0
62,298Form 4
ROSENOW EDWARD C III
Director
2012-03-30 17:31:0145,540
0
45,540Form 4
KJAER PETER
Director
2010-04-02 16:26:5144,425
0
44,425Form 4
Mutz Christopher
HEAD OF RARE DISEASE
2022-04-29 18:37:1540,854
0
40,854Form 4
HAUGHEY THOMAS
Director
2022-04-29 18:31:5040,251
0
40,251Form 4
Gutwerg Ori
SVP GENERICS
2022-04-29 18:38:0437,644
0
37,644Form 4
NASH DAVID
Director
2022-04-29 18:28:3731,696
0
31,696Form 4
POTTS JOHN T JR
Director
2012-03-30 17:34:4127,657
2924
30,581Form 4
Pera Antonio R
Director
2022-04-29 18:27:2729,762
0
29,762Form 4
Thoma Jeanne
Director
2022-04-29 18:26:0329,334
0
29,334Form 4
MANGANO ROSS J
Director
2014-09-16 16:40:5726,914
0
26,914Form 4
BELL STEVEN J
VP Research & Pre-Clinical Dev
2005-08-25 15:32:2725,000
0
25,000Form 4/A
Cook Meredith
SR. VP GENERAL COUNSEL & SEC.
2022-07-20 16:48:1619,280
0
19,280Form 4
Penn Thomas A.
Director
2019-04-01 16:00:2116,710
0
16,710Form 4
Davis Krista
SVP CHIEF HR OFFICER
2022-09-14 19:06:0116,433
0
16,433Form 4
HOLUBOW FRED
Director
2018-03-22 17:00:3516,144
0
16,144Form 4
TANNENBAUM RENEE P
Director
2022-03-22 17:36:2513,346
0
13,346Form 4
LANKAU PETER A
Director
2016-04-11 18:58:164500
0
4500Form 4
MORGENSTERN VICTOR A
Director
2007-06-14 16:53:130
0
0Form 4